Replimune Group, Inc. (REPL)
9.82
-0.48
(-4.66%)
USD |
NASDAQ |
Dec 10, 16:00
9.60
-0.22
(-2.24%)
After-Hours: 04:07
Replimune Group Market Cap: 770.31M for Dec. 10, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Rapt Therapeutics, Inc. | 605.61M |
| Olema Pharmaceuticals, Inc. | 2.106B |
| CorMedix, Inc. | 903.71M |
| Verastem, Inc. | 753.95M |
| Anavex Life Sciences Corp. | 364.54M |
Market Cap Related Metrics
| PEG Ratio | -0.1727 |
| Price to Book Value | 2.925 |
| Price | 9.82 |
| Earnings Yield | -36.74% |
| PEGY Ratio | -0.1727 |